Imbruvica 140 mg

Imbruvica 140 mg (Ibrutinib)

Active IngredientIbrutinib
Dosage FormCapsule
Available Strength140mg
Manufacturer:Johnson & Johnson
Packaging90 capsules in 1 bottle
Therapeutic useMantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)
Pack Insert/LeafletYes
Production Capacity1 Million Bottle's/Month

Description